The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS).

Wassell, J; Michail, M; Soliman, N; Wardle, P G

Wassell, J; Michail, M; Soliman, N; Wardle, P G.

Affiliation

Wassell J; Department of Biochemistry, Southmead Hospital, Bristol BS16 1LE, UK. Julie.wassell@nbt.nhs.uk

Clin Lab ; 57(1-2): 95-8, 2011.

Article in En | MEDLINE | ID: mdl-21391472

Subject(s)

Biomarkers/blood; Hypoglycemic Agents/therapeutic use; Polycystic Ovary Syndrome/drug therapy; Sex Hormone-Binding Globulin/analysis; Adult; Case-Control Studies; Female; Humans; Metformin/therapeutic use; Polycystic Ovary Syndrome/diagnosis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polycystic Ovary Syndrome / Sex Hormone-Binding Globulin / Biomarkers / Hypoglycemic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Clin Lab Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2011 Document type: Article Affiliation country: United kingdom Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links